Orionis Biosciences, Inc.
Records under this name other than the patents Orionis Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
Back to Orionis Biosciences, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,753,463 | Therapeutic Targeting of Non-Cellular Structures Formerly held In force · High confidence | In force | High confidence | |
| US 11,236,141 | Targeted Mutant Interferon-Beta and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 12,497,436 | Chimeric Protein, and Encoding Nucleic Acid Thereof, Comprising Interferon-Beta and a Targeting Moiety Comprising a Single-Domain Antibody or Single-Chain Antibody Formerly held In force · High confidence | In force | High confidence | |
| US 10,906,985 | Targeted Engineered Interferon and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 12,473,338 | Targeted Engineered Interferon and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 12,448,447 | CD8 binding agents Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,498,966 | PD-1 and PD-L1 Binding Agents Formerly held In force · High confidence | In force | High confidence | |
| US 11,566,072 | CD8 binding agents Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,091,463 | CLEC9A Binding Agents Comprising a Recombinant Heavy-Chain Only Antibody (VHH) Formerly held In force · High confidence | In force | High confidence | |
| US 12,351,633 | PD-1 and PD-L1 Binding Agents Formerly held In force · High confidence | In force | High confidence |